High-throughput transcriptome profiling indicates ribosomal RNAs to be associated with resistance to immunotherapy in non-small cell lung cancer (NSCLC)
Background Despite the impressive outcomes with immune checkpoint inhibitor (ICI) in non-small cell lung cancer (NSCLC), only a minority of the patients show long-term benefits from ICI. In this study, we used retrospective cohorts of ICI treated patients with NSCLC to discover and validate spatiall...
שמור ב:
| Principais autores: | , , , , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BMJ Publishing Group
2024-06-01
|
| סדרה: | Journal for ImmunoTherapy of Cancer |
| גישה מקוונת: | https://jitc.bmj.com/content/12/6/e009039.full |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
